Industry Research Reports

Home > Reports > Chemical & Material > Global Olmesartan Medoxomil API Market Research Report 2024

Global Olmesartan Medoxomil API Market Research Report 2024

Industry: Chemical & Material

Published Date: 2024-02-07

Pages: 115 Pages

Report ld: 2470927

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Olmesartan Medoxomil API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Olmesartan Medoxomil API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Olmesartan Medoxomil API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Olmesartan Medoxomil API include Rundu Pharma, Tianyu Pharmaceutical, Weightech (Hunan) Pharmaceutical, Ningbo Menovo Pharmaceutical, CR Double-Crane, Acebright Pharmaceuticals, Zhejiang East-asia Pharmaceutical, Hunan Ouya and Divi's Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Olmesartan Medoxomil API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olmesartan Medoxomil API.

MARKET SEGMENTATION

By Company

Rundu Pharma
Tianyu Pharmaceutical
Weightech (Hunan) Pharmaceutical
Ningbo Menovo Pharmaceutical
CR Double-Crane
Acebright Pharmaceuticals
Zhejiang East-asia Pharmaceutical
Hunan Ouya
Divi's Laboratories
Tecoland
Verdant Life Sciences
SMILAX
Atom Pharma
Accura Labs
Biophore
Aalidhra Pharmachem

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity ≥ 99.5%
Purity ≥ 99.9%

Segment by Application

Tablet
Capsule
Others

biaoTi REPORT SCOPE

The Olmesartan Medoxomil API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Olmesartan Medoxomil API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Olmesartan Medoxomil API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Olmesartan Medoxomil API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Olmesartan Medoxomil API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Olmesartan Medoxomil API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Olmesartan Medoxomil API Market Overview

1.1 Product Definition

1.2 Olmesartan Medoxomil API Segment by Type

1.2.1 Global Olmesartan Medoxomil API Market Value Growth Rate Analysis by Type 2023 VS 2030

1.2.2 Purity ≥ 99.5%

1.2.3 Purity ≥ 99.9%

1.3 Olmesartan Medoxomil API Segment by Application

1.3.1 Global Olmesartan Medoxomil API Market Value Growth Rate Analysis by Application: 2023 VS 2030

1.3.2 Tablet

1.3.3 Capsule

1.3.4 Others

1.4 Global Market Growth Prospects

1.4.1 Global Olmesartan Medoxomil API Production Value Estimates and Forecasts (2019-2030)

1.4.2 Global Olmesartan Medoxomil API Production Capacity Estimates and Forecasts (2019-2030)

1.4.3 Global Olmesartan Medoxomil API Production Estimates and Forecasts (2019-2030)

1.4.4 Global Olmesartan Medoxomil API Market Average Price Estimates and Forecasts (2019-2030)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Olmesartan Medoxomil API Production Market Share by Manufacturers (2019-2024)

2.2 Global Olmesartan Medoxomil API Production Value Market Share by Manufacturers (2019-2024)

2.3 Global Key Players of Olmesartan Medoxomil API, Industry Ranking, 2022 VS 2023 VS 2024

2.4 Global Olmesartan Medoxomil API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.5 Global Olmesartan Medoxomil API Average Price by Manufacturers (2019-2024)

2.6 Global Key Manufacturers of Olmesartan Medoxomil API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Olmesartan Medoxomil API, Product Offered and Application

2.8 Global Key Manufacturers of Olmesartan Medoxomil API, Date of Enter into This Industry

2.9 Olmesartan Medoxomil API Market Competitive Situation and Trends

2.9.1 Olmesartan Medoxomil API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Olmesartan Medoxomil API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Olmesartan Medoxomil API Production by Region

3.1 Global Olmesartan Medoxomil API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.2 Global Olmesartan Medoxomil API Production Value by Region (2019-2030)

3.2.1 Global Olmesartan Medoxomil API Production Value Market Share by Region (2019-2024)

3.2.2 Global Forecasted Production Value of Olmesartan Medoxomil API by Region (2025-2030)

3.3 Global Olmesartan Medoxomil API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.4 Global Olmesartan Medoxomil API Production by Region (2019-2030)

3.4.1 Global Olmesartan Medoxomil API Production Market Share by Region (2019-2024)

3.4.2 Global Forecasted Production of Olmesartan Medoxomil API by Region (2025-2030)

3.5 Global Olmesartan Medoxomil API Market Price Analysis by Region (2019-2024)

3.6 Global Olmesartan Medoxomil API Production and Value, Year-over-Year Growth

3.6.1 North America Olmesartan Medoxomil API Production Value Estimates and Forecasts (2019-2030)

3.6.2 Europe Olmesartan Medoxomil API Production Value Estimates and Forecasts (2019-2030)

3.6.3 China Olmesartan Medoxomil API Production Value Estimates and Forecasts (2019-2030)

3.6.4 India Olmesartan Medoxomil API Production Value Estimates and Forecasts (2019-2030)

4 Olmesartan Medoxomil API Consumption by Region

4.1 Global Olmesartan Medoxomil API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

4.2 Global Olmesartan Medoxomil API Consumption by Region (2019-2030)

4.2.1 Global Olmesartan Medoxomil API Consumption by Region (2019-2024)

4.2.2 Global Olmesartan Medoxomil API Forecasted Consumption by Region (2025-2030)

4.3 North America

4.3.1 North America Olmesartan Medoxomil API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.3.2 North America Olmesartan Medoxomil API Consumption by Country (2019-2030)

4.3.3 United States

4.3.4 Canada

4.4 Europe

4.4.1 Europe Olmesartan Medoxomil API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.4.2 Europe Olmesartan Medoxomil API Consumption by Country (2019-2030)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Olmesartan Medoxomil API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030

4.5.2 Asia Pacific Olmesartan Medoxomil API Consumption by Region (2019-2030)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Olmesartan Medoxomil API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.6.2 Latin America, Middle East & Africa Olmesartan Medoxomil API Consumption by Country (2019-2030)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

5 Segment by Type

5.1 Global Olmesartan Medoxomil API Production by Type (2019-2030)

5.1.1 Global Olmesartan Medoxomil API Production by Type (2019-2024)

5.1.2 Global Olmesartan Medoxomil API Production by Type (2025-2030)

5.1.3 Global Olmesartan Medoxomil API Production Market Share by Type (2019-2030)

5.2 Global Olmesartan Medoxomil API Production Value by Type (2019-2030)

5.2.1 Global Olmesartan Medoxomil API Production Value by Type (2019-2024)

5.2.2 Global Olmesartan Medoxomil API Production Value by Type (2025-2030)

5.2.3 Global Olmesartan Medoxomil API Production Value Market Share by Type (2019-2030)

5.3 Global Olmesartan Medoxomil API Price by Type (2019-2030)

6 Segment by Application

6.1 Global Olmesartan Medoxomil API Production by Application (2019-2030)

6.1.1 Global Olmesartan Medoxomil API Production by Application (2019-2024)

6.1.2 Global Olmesartan Medoxomil API Production by Application (2025-2030)

6.1.3 Global Olmesartan Medoxomil API Production Market Share by Application (2019-2030)

6.2 Global Olmesartan Medoxomil API Production Value by Application (2019-2030)

6.2.1 Global Olmesartan Medoxomil API Production Value by Application (2019-2024)

6.2.2 Global Olmesartan Medoxomil API Production Value by Application (2025-2030)

6.2.3 Global Olmesartan Medoxomil API Production Value Market Share by Application (2019-2030)

6.3 Global Olmesartan Medoxomil API Price by Application (2019-2030)

7 Key Companies Profiled

7.1 Rundu Pharma

7.1.1 Rundu Pharma Olmesartan Medoxomil API Corporation Information

7.1.2 Rundu Pharma Olmesartan Medoxomil API Product Portfolio

7.1.3 Rundu Pharma Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.1.4 Rundu Pharma Main Business and Markets Served

7.1.5 Rundu Pharma Recent Developments/Updates

7.2 Tianyu Pharmaceutical

7.2.1 Tianyu Pharmaceutical Olmesartan Medoxomil API Corporation Information

7.2.2 Tianyu Pharmaceutical Olmesartan Medoxomil API Product Portfolio

7.2.3 Tianyu Pharmaceutical Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.2.4 Tianyu Pharmaceutical Main Business and Markets Served

7.2.5 Tianyu Pharmaceutical Recent Developments/Updates

7.3 Weightech (Hunan) Pharmaceutical

7.3.1 Weightech (Hunan) Pharmaceutical Olmesartan Medoxomil API Corporation Information

7.3.2 Weightech (Hunan) Pharmaceutical Olmesartan Medoxomil API Product Portfolio

7.3.3 Weightech (Hunan) Pharmaceutical Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.3.4 Weightech (Hunan) Pharmaceutical Main Business and Markets Served

7.3.5 Weightech (Hunan) Pharmaceutical Recent Developments/Updates

7.4 Ningbo Menovo Pharmaceutical

7.4.1 Ningbo Menovo Pharmaceutical Olmesartan Medoxomil API Corporation Information

7.4.2 Ningbo Menovo Pharmaceutical Olmesartan Medoxomil API Product Portfolio

7.4.3 Ningbo Menovo Pharmaceutical Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.4.4 Ningbo Menovo Pharmaceutical Main Business and Markets Served

7.4.5 Ningbo Menovo Pharmaceutical Recent Developments/Updates

7.5 CR Double-Crane

7.5.1 CR Double-Crane Olmesartan Medoxomil API Corporation Information

7.5.2 CR Double-Crane Olmesartan Medoxomil API Product Portfolio

7.5.3 CR Double-Crane Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.5.4 CR Double-Crane Main Business and Markets Served

7.5.5 CR Double-Crane Recent Developments/Updates

7.6 Acebright Pharmaceuticals

7.6.1 Acebright Pharmaceuticals Olmesartan Medoxomil API Corporation Information

7.6.2 Acebright Pharmaceuticals Olmesartan Medoxomil API Product Portfolio

7.6.3 Acebright Pharmaceuticals Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.6.4 Acebright Pharmaceuticals Main Business and Markets Served

7.6.5 Acebright Pharmaceuticals Recent Developments/Updates

7.7 Zhejiang East-asia Pharmaceutical

7.7.1 Zhejiang East-asia Pharmaceutical Olmesartan Medoxomil API Corporation Information

7.7.2 Zhejiang East-asia Pharmaceutical Olmesartan Medoxomil API Product Portfolio

7.7.3 Zhejiang East-asia Pharmaceutical Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.7.4 Zhejiang East-asia Pharmaceutical Main Business and Markets Served

7.7.5 Zhejiang East-asia Pharmaceutical Recent Developments/Updates

7.8 Hunan Ouya

7.8.1 Hunan Ouya Olmesartan Medoxomil API Corporation Information

7.8.2 Hunan Ouya Olmesartan Medoxomil API Product Portfolio

7.8.3 Hunan Ouya Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.8.4 Hunan Ouya Main Business and Markets Served

7.7.5 Hunan Ouya Recent Developments/Updates

7.9 Divi's Laboratories

7.9.1 Divi's Laboratories Olmesartan Medoxomil API Corporation Information

7.9.2 Divi's Laboratories Olmesartan Medoxomil API Product Portfolio

7.9.3 Divi's Laboratories Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.9.4 Divi's Laboratories Main Business and Markets Served

7.9.5 Divi's Laboratories Recent Developments/Updates

7.10 Tecoland

7.10.1 Tecoland Olmesartan Medoxomil API Corporation Information

7.10.2 Tecoland Olmesartan Medoxomil API Product Portfolio

7.10.3 Tecoland Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.10.4 Tecoland Main Business and Markets Served

7.10.5 Tecoland Recent Developments/Updates

7.11 Verdant Life Sciences

7.11.1 Verdant Life Sciences Olmesartan Medoxomil API Corporation Information

7.11.2 Verdant Life Sciences Olmesartan Medoxomil API Product Portfolio

7.11.3 Verdant Life Sciences Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.11.4 Verdant Life Sciences Main Business and Markets Served

7.11.5 Verdant Life Sciences Recent Developments/Updates

7.12 SMILAX

7.12.1 SMILAX Olmesartan Medoxomil API Corporation Information

7.12.2 SMILAX Olmesartan Medoxomil API Product Portfolio

7.12.3 SMILAX Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.12.4 SMILAX Main Business and Markets Served

7.12.5 SMILAX Recent Developments/Updates

7.13 Atom Pharma

7.13.1 Atom Pharma Olmesartan Medoxomil API Corporation Information

7.13.2 Atom Pharma Olmesartan Medoxomil API Product Portfolio

7.13.3 Atom Pharma Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.13.4 Atom Pharma Main Business and Markets Served

7.13.5 Atom Pharma Recent Developments/Updates

7.14 Accura Labs

7.14.1 Accura Labs Olmesartan Medoxomil API Corporation Information

7.14.2 Accura Labs Olmesartan Medoxomil API Product Portfolio

7.14.3 Accura Labs Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.14.4 Accura Labs Main Business and Markets Served

7.14.5 Accura Labs Recent Developments/Updates

7.15 Biophore

7.15.1 Biophore Olmesartan Medoxomil API Corporation Information

7.15.2 Biophore Olmesartan Medoxomil API Product Portfolio

7.15.3 Biophore Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.15.4 Biophore Main Business and Markets Served

7.15.5 Biophore Recent Developments/Updates

7.16 Aalidhra Pharmachem

7.16.1 Aalidhra Pharmachem Olmesartan Medoxomil API Corporation Information

7.16.2 Aalidhra Pharmachem Olmesartan Medoxomil API Product Portfolio

7.16.3 Aalidhra Pharmachem Olmesartan Medoxomil API Production, Value, Price and Gross Margin (2019-2024)

7.16.4 Aalidhra Pharmachem Main Business and Markets Served

7.16.5 Aalidhra Pharmachem Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Olmesartan Medoxomil API Industry Chain Analysis

8.2 Olmesartan Medoxomil API Key Raw Materials

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Olmesartan Medoxomil API Production Mode & Process

8.4 Olmesartan Medoxomil API Sales and Marketing

8.4.1 Olmesartan Medoxomil API Sales Channels

8.4.2 Olmesartan Medoxomil API Distributors

8.5 Olmesartan Medoxomil API Customers

9 Olmesartan Medoxomil API Market Dynamics

9.1 Olmesartan Medoxomil API Industry Trends

9.2 Olmesartan Medoxomil API Market Drivers

9.3 Olmesartan Medoxomil API Market Challenges

9.4 Olmesartan Medoxomil API Market Restraints

10 Research Finding and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Olmesartan Medoxomil API Market Value by Type, (US$ Million) & (2023 VS 2030)

Table 2. Global Olmesartan Medoxomil API Market Value by Application, (US$ Million) & (2023 VS 2030)

Table 3. Global Olmesartan Medoxomil API Production Capacity (Tons) by Manufacturers in 2023

Table 4. Global Olmesartan Medoxomil API Production by Manufacturers (2019-2024) & (Tons)

Table 5. Global Olmesartan Medoxomil API Production Market Share by Manufacturers (2019-2024)

Table 6. Global Olmesartan Medoxomil API Production Value by Manufacturers (2019-2024) & (US$ Million)

Table 7. Global Olmesartan Medoxomil API Production Value Share by Manufacturers (2019-2024)

Table 8. Global Olmesartan Medoxomil API Industry Ranking 2022 VS 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Olmesartan Medoxomil API as of 2023)

Table 10. Global Market Olmesartan Medoxomil API Average Price by Manufacturers (US$/Ton) & (2019-2024)

Table 11. Manufacturers Olmesartan Medoxomil API Production Sites and Area Served

Table 12. Manufacturers Olmesartan Medoxomil API Product Types

Table 13. Global Olmesartan Medoxomil API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion

Table 15. Global Olmesartan Medoxomil API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 16. Global Olmesartan Medoxomil API Production Value (US$ Million) by Region (2019-2024)

Table 17. Global Olmesartan Medoxomil API Production Value Market Share by Region (2019-2024)

Table 18. Global Olmesartan Medoxomil API Production Value (US$ Million) Forecast by Region (2025-2030)

Table 19. Global Olmesartan Medoxomil API Production Value Market Share Forecast by Region (2025-2030)

Table 20. Global Olmesartan Medoxomil API Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)

Table 21. Global Olmesartan Medoxomil API Production (Tons) by Region (2019-2024)

Table 22. Global Olmesartan Medoxomil API Production Market Share by Region (2019-2024)

Table 23. Global Olmesartan Medoxomil API Production (Tons) Forecast by Region (2025-2030)

Table 24. Global Olmesartan Medoxomil API Production Market Share Forecast by Region (2025-2030)

Table 25. Global Olmesartan Medoxomil API Market Average Price (US$/Ton) by Region (2019-2024)

Table 26. Global Olmesartan Medoxomil API Market Average Price (US$/Ton) by Region (2025-2030)

Table 27. Global Olmesartan Medoxomil API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)

Table 28. Global Olmesartan Medoxomil API Consumption by Region (2019-2024) & (Tons)

Table 29. Global Olmesartan Medoxomil API Consumption Market Share by Region (2019-2024)

Table 30. Global Olmesartan Medoxomil API Forecasted Consumption by Region (2025-2030) & (Tons)

Table 31. Global Olmesartan Medoxomil API Forecasted Consumption Market Share by Region (2019-2024)

Table 32. North America Olmesartan Medoxomil API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)

Table 33. North America Olmesartan Medoxomil API Consumption by Country (2019-2024) & (Tons)

Table 34. North America Olmesartan Medoxomil API Consumption by Country (2025-2030) & (Tons)

Table 35. Europe Olmesartan Medoxomil API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)

Table 36. Europe Olmesartan Medoxomil API Consumption by Country (2019-2024) & (Tons)

Table 37. Europe Olmesartan Medoxomil API Consumption by Country (2025-2030) & (Tons)

Table 38. Asia Pacific Olmesartan Medoxomil API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)

Table 39. Asia Pacific Olmesartan Medoxomil API Consumption by Region (2019-2024) & (Tons)

Table 40. Asia Pacific Olmesartan Medoxomil API Consumption by Region (2025-2030) & (Tons)

Table 41. Latin America, Middle East & Africa Olmesartan Medoxomil API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)

Table 42. Latin America, Middle East & Africa Olmesartan Medoxomil API Consumption by Country (2019-2024) & (Tons)

Table 43. Latin America, Middle East & Africa Olmesartan Medoxomil API Consumption by Country (2025-2030) & (Tons)

Table 44. Global Olmesartan Medoxomil API Production (Tons) by Type (2019-2024)

Table 45. Global Olmesartan Medoxomil API Production (Tons) by Type (2025-2030)

Table 46. Global Olmesartan Medoxomil API Production Market Share by Type (2019-2024)

Table 47. Global Olmesartan Medoxomil API Production Market Share by Type (2025-2030)

Table 48. Global Olmesartan Medoxomil API Production Value (US$ Million) by Type (2019-2024)

Table 49. Global Olmesartan Medoxomil API Production Value (US$ Million) by Type (2025-2030)

Table 50. Global Olmesartan Medoxomil API Production Value Share by Type (2019-2024)

Table 51. Global Olmesartan Medoxomil API Production Value Share by Type (2025-2030)

Table 52. Global Olmesartan Medoxomil API Price (US$/Ton) by Type (2019-2024)

Table 53. Global Olmesartan Medoxomil API Price (US$/Ton) by Type (2025-2030)

Table 54. Global Olmesartan Medoxomil API Production (Tons) by Application (2019-2024)

Table 55. Global Olmesartan Medoxomil API Production (Tons) by Application (2025-2030)

Table 56. Global Olmesartan Medoxomil API Production Market Share by Application (2019-2024)

Table 57. Global Olmesartan Medoxomil API Production Market Share by Application (2025-2030)

Table 58. Global Olmesartan Medoxomil API Production Value (US$ Million) by Application (2019-2024)

Table 59. Global Olmesartan Medoxomil API Production Value (US$ Million) by Application (2025-2030)

Table 60. Global Olmesartan Medoxomil API Production Value Share by Application (2019-2024)

Table 61. Global Olmesartan Medoxomil API Production Value Share by Application (2025-2030)

Table 62. Global Olmesartan Medoxomil API Price (US$/Ton) by Application (2019-2024)

Table 63. Global Olmesartan Medoxomil API Price (US$/Ton) by Application (2025-2030)

Table 64. Rundu Pharma Olmesartan Medoxomil API Corporation Information

Table 65. Rundu Pharma Specification and Application

Table 66. Rundu Pharma Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 67. Rundu Pharma Main Business and Markets Served

Table 68. Rundu Pharma Recent Developments/Updates

Table 69. Tianyu Pharmaceutical Olmesartan Medoxomil API Corporation Information

Table 70. Tianyu Pharmaceutical Specification and Application

Table 71. Tianyu Pharmaceutical Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 72. Tianyu Pharmaceutical Main Business and Markets Served

Table 73. Tianyu Pharmaceutical Recent Developments/Updates

Table 74. Weightech (Hunan) Pharmaceutical Olmesartan Medoxomil API Corporation Information

Table 75. Weightech (Hunan) Pharmaceutical Specification and Application

Table 76. Weightech (Hunan) Pharmaceutical Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 77. Weightech (Hunan) Pharmaceutical Main Business and Markets Served

Table 78. Weightech (Hunan) Pharmaceutical Recent Developments/Updates

Table 79. Ningbo Menovo Pharmaceutical Olmesartan Medoxomil API Corporation Information

Table 80. Ningbo Menovo Pharmaceutical Specification and Application

Table 81. Ningbo Menovo Pharmaceutical Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 82. Ningbo Menovo Pharmaceutical Main Business and Markets Served

Table 83. Ningbo Menovo Pharmaceutical Recent Developments/Updates

Table 84. CR Double-Crane Olmesartan Medoxomil API Corporation Information

Table 85. CR Double-Crane Specification and Application

Table 86. CR Double-Crane Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 87. CR Double-Crane Main Business and Markets Served

Table 88. CR Double-Crane Recent Developments/Updates

Table 89. Acebright Pharmaceuticals Olmesartan Medoxomil API Corporation Information

Table 90. Acebright Pharmaceuticals Specification and Application

Table 91. Acebright Pharmaceuticals Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 92. Acebright Pharmaceuticals Main Business and Markets Served

Table 93. Acebright Pharmaceuticals Recent Developments/Updates

Table 94. Zhejiang East-asia Pharmaceutical Olmesartan Medoxomil API Corporation Information

Table 95. Zhejiang East-asia Pharmaceutical Specification and Application

Table 96. Zhejiang East-asia Pharmaceutical Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 97. Zhejiang East-asia Pharmaceutical Main Business and Markets Served

Table 98. Zhejiang East-asia Pharmaceutical Recent Developments/Updates

Table 99. Hunan Ouya Olmesartan Medoxomil API Corporation Information

Table 100. Hunan Ouya Specification and Application

Table 101. Hunan Ouya Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 102. Hunan Ouya Main Business and Markets Served

Table 103. Hunan Ouya Recent Developments/Updates

Table 104. Divi's Laboratories Olmesartan Medoxomil API Corporation Information

Table 105. Divi's Laboratories Specification and Application

Table 106. Divi's Laboratories Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 107. Divi's Laboratories Main Business and Markets Served

Table 108. Divi's Laboratories Recent Developments/Updates

Table 109. Tecoland Olmesartan Medoxomil API Corporation Information

Table 110. Tecoland Specification and Application

Table 111. Tecoland Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 112. Tecoland Main Business and Markets Served

Table 113. Tecoland Recent Developments/Updates

Table 114. Verdant Life Sciences Olmesartan Medoxomil API Corporation Information

Table 115. Verdant Life Sciences Specification and Application

Table 116. Verdant Life Sciences Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 117. Verdant Life Sciences Main Business and Markets Served

Table 118. Verdant Life Sciences Recent Developments/Updates

Table 119. SMILAX Olmesartan Medoxomil API Corporation Information

Table 120. SMILAX Specification and Application

Table 121. SMILAX Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 122. SMILAX Main Business and Markets Served

Table 123. SMILAX Recent Developments/Updates

Table 124. Atom Pharma Olmesartan Medoxomil API Corporation Information

Table 125. Atom Pharma Specification and Application

Table 126. Atom Pharma Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 127. Atom Pharma Main Business and Markets Served

Table 128. Atom Pharma Recent Developments/Updates

Table 129. Accura Labs Olmesartan Medoxomil API Corporation Information

Table 130. Accura Labs Specification and Application

Table 131. Accura Labs Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 132. Accura Labs Main Business and Markets Served

Table 133. Accura Labs Recent Developments/Updates

Table 134. Accura Labs Olmesartan Medoxomil API Corporation Information

Table 135. Biophore Specification and Application

Table 136. Biophore Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 137. Biophore Main Business and Markets Served

Table 138. Biophore Recent Developments/Updates

Table 139. Aalidhra Pharmachem Olmesartan Medoxomil API Corporation Information

Table 140. Aalidhra Pharmachem Olmesartan Medoxomil API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 141. Aalidhra Pharmachem Main Business and Markets Served

Table 142. Aalidhra Pharmachem Recent Developments/Updates

Table 143. Key Raw Materials Lists

Table 144. Raw Materials Key Suppliers Lists

Table 145. Olmesartan Medoxomil API Distributors List

Table 146. Olmesartan Medoxomil API Customers List

Table 147. Olmesartan Medoxomil API Market Trends

Table 148. Olmesartan Medoxomil API Market Drivers

Table 149. Olmesartan Medoxomil API Market Challenges

Table 150. Olmesartan Medoxomil API Market Restraints

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Olmesartan Medoxomil API

Figure 2. Global Olmesartan Medoxomil API Market Value by Type, (US$ Million) & (2023 VS 2030)

Figure 3. Global Olmesartan Medoxomil API Market Share by Type: 2023 VS 2030

Figure 4. Purity ≥ 99.5% Product Picture

Figure 5. Purity ≥ 99.9% Product Picture

Figure 6. Global Olmesartan Medoxomil API Market Value by Application, (US$ Million) & (2023 VS 2030)

Figure 7. Global Olmesartan Medoxomil API Market Share by Application: 2023 VS 2030

Figure 8. Tablet

Figure 9. Capsule

Figure 10. Others

Figure 11. Global Olmesartan Medoxomil API Production Value (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Olmesartan Medoxomil API Production Value (US$ Million) & (2019-2030)

Figure 13. Global Olmesartan Medoxomil API Production Capacity (Tons) & (2019-2030)

Figure 14. Global Olmesartan Medoxomil API Production (Tons) & (2019-2030)

Figure 15. Global Olmesartan Medoxomil API Average Price (US$/Ton) & (2019-2030)

Figure 16. Olmesartan Medoxomil API Report Years Considered

Figure 17. Olmesartan Medoxomil API Production Share by Manufacturers in 2023

Figure 18. Olmesartan Medoxomil API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 19. The Global 5 and 10 Largest Players: Market Share by Olmesartan Medoxomil API Revenue in 2023

Figure 20. Global Olmesartan Medoxomil API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 21. Global Olmesartan Medoxomil API Production Value Market Share by Region: 2019 VS 2023 VS 2030

Figure 22. Global Olmesartan Medoxomil API Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)

Figure 23. Global Olmesartan Medoxomil API Production Market Share by Region: 2019 VS 2023 VS 2030

Figure 24. North America Olmesartan Medoxomil API Production Value (US$ Million) Growth Rate (2019-2030)

Figure 25. Europe Olmesartan Medoxomil API Production Value (US$ Million) Growth Rate (2019-2030)

Figure 26. China Olmesartan Medoxomil API Production Value (US$ Million) Growth Rate (2019-2030)

Figure 27. India Olmesartan Medoxomil API Production Value (US$ Million) Growth Rate (2019-2030)

Figure 28. Global Olmesartan Medoxomil API Consumption by Region: 2019 VS 2023 VS 2030 (Tons)

Figure 29. Global Olmesartan Medoxomil API Consumption Market Share by Region: 2019 VS 2023 VS 2030

Figure 30. North America Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 31. North America Olmesartan Medoxomil API Consumption Market Share by Country (2019-2030)

Figure 32. Canada Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 33. U.S. Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 34. Europe Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 35. Europe Olmesartan Medoxomil API Consumption Market Share by Country (2019-2030)

Figure 36. Germany Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 37. France Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 38. U.K. Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 39. Italy Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 40. Russia Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 41. Asia Pacific Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 42. Asia Pacific Olmesartan Medoxomil API Consumption Market Share by Regions (2019-2030)

Figure 43. China Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 44. Japan Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 45. South Korea Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 46. China Taiwan Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 47. Southeast Asia Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 48. India Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 49. Latin America, Middle East & Africa Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 50. Latin America, Middle East & Africa Olmesartan Medoxomil API Consumption Market Share by Country (2019-2030)

Figure 51. Mexico Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 52. Brazil Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 53. Turkey Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 54. GCC Countries Olmesartan Medoxomil API Consumption and Growth Rate (2019-2024) & (Tons)

Figure 55. Global Production Market Share of Olmesartan Medoxomil API by Type (2019-2030)

Figure 56. Global Production Value Market Share of Olmesartan Medoxomil API by Type (2019-2030)

Figure 57. Global Olmesartan Medoxomil API Price (US$/Ton) by Type (2019-2030)

Figure 58. Global Production Market Share of Olmesartan Medoxomil API by Application (2019-2030)

Figure 59. Global Production Value Market Share of Olmesartan Medoxomil API by Application (2019-2030)

Figure 60. Global Olmesartan Medoxomil API Price (US$/Ton) by Application (2019-2030)

Figure 61. Olmesartan Medoxomil API Value Chain

Figure 62. Olmesartan Medoxomil API Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Olmesartan Medoxomil API market? zhanKai

The top companies in the global Olmesartan Medoxomil API market are Rundu Pharma、Tianyu Pharmaceutical、Weightech (Hunan) Pharmaceutical.

Related Reports

Olmesartan Medoxomil API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Olmesartan Medoxomil API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 152
USD 3950.00
(Single User License)
Global Olmesartan Medoxomil API Market Research Report 2026
The global Olmesartan Medoxomil API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 150
USD 2900.00
(Single User License)
Global Olmesartan Medoxomil API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Olmesartan Medoxomil API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 104
USD 4250.00
(Single User License)
Global Olmesartan Medoxomil API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Olmesartan Medoxomil API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 175
USD 4900.00
(Single User License)
Olmesartan Medoxomil API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Olmesartan Medoxomil API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 138
USD 3950.00
(Single User License)
Global Olmesartan Medoxomil API Market Research Report 2025
The global market for Olmesartan Medoxomil API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 115
USD 2900.00
(Single User License)

Olmesartan Medoxomil API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Olmesartan Medoxomil API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 152
USD 3950.00 (Single User License)
Global Olmesartan Medoxomil API Market Research Report 2026
The global Olmesartan Medoxomil API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 150
USD 2900.00 (Single User License)
Global Olmesartan Medoxomil API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Olmesartan Medoxomil API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 104
USD 4250.00 (Single User License)
Global Olmesartan Medoxomil API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Olmesartan Medoxomil API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 175
USD 4900.00 (Single User License)
Olmesartan Medoxomil API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Olmesartan Medoxomil API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 138
USD 3950.00 (Single User License)
Global Olmesartan Medoxomil API Market Research Report 2025
The global market for Olmesartan Medoxomil API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 115
USD 2900.00 (Single User License)